1-5 of 5
A. W Rijneveld
Close
Sort by
Journal Articles

Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in Progress

Annelies J. Van Vuren, MD, Bart J. Biemond, MD PhD, Jean-Louis Kerkhoffs, MD PhD, Saskia E.M. Schols, MD PhD, A. W. Rijneveld, MD PhD, Erfan Nur, MD PhD, Richard van Wijk, PhD, Tim Leiner, MD PhD, Joannes J.M. Marx, Emeritus Professor, Eduard J. van Beers, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 960.
https://doi.org/10.1182/blood-2019-124059
Published: 2019
Journal Articles

Incentive Spirometry to Prevent Acute Chest Syndrome in Adults with Sickle Cell Disease

Bart J. Biemond, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD, Aafke E. Gaartman, MD, Erfan Nur, MD PhD, A. W. Rijneveld, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3660.
https://doi.org/10.1182/blood-2018-99-117450
Published: 2018
Journal Articles

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

A. W. Rijneveld, Bronno van der Holt, Okke de Weerdt, MD, Bart J. Biemond, MD PhD, Arjen van de Loosdrecht, Eefke Petersen, MD, Mar Bellido, Harry C. Schouten, MD, Walter J F M van der Velden, Dominik Selleslag, Martin R. Schipperus, Constantijn J.M. Halkes, Saskia Klein, MD, Violaine Havelange, Marinus van Marwijk Kooij, MD PhD, Marie-Cecile Legdeur, Jeannine Refos, Vincent van der Velden, PhD, Jan J Cornelissen, Crista Homburg, Valerie de Haas, MD PhD, Dries Deeren, MD, Alain Gaddiseur, Harm Sinnige, Dimitri Breems, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2606.
https://doi.org/10.1182/blood.V130.Suppl_1.2606.2606
Published: 2017
Journal Articles

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

Joep W.R. Sins, MDMSc, Xiaoyun Fu, PhD, Karin Fijnvandraat, MD PhD, Melissa Dominguez, MA, A. W. Rijneveld, Jean-Louis Kerkhoffs, MD PhD, A van Meurs, MD, M. R. De Groot, MD, H Heijboer, MD PhD, Erfan Nur, MD PhD, Brenda M Luken, PhD, Sacha S Zeerleder, MD PhD, Marie-Françoise Dresse, Phu-Quoc Le, MD, Philippe Hermans, MD PhD, Anna Vanderfaeillie, MD, Eric Van Den Neste, Fleur Samantha Benghiat, Rachel Kesse-Adu, MD, Andre Delannoy, MD, Andre Efira, MD, Marie-Agnes Azerad, MD, C A de Borgie, MD PhD, Junmei Chen, PhD, Jose A. Lopez, MD, Bart J. Biemond, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2244.
https://doi.org/10.1182/blood.V130.Suppl_1.2244.2244
Published: 2017
Journal Articles

High Dose Intensive Chemotherapy, as Is Standard in Childhood Leukemia, Is Feasible and Efficacious in Adult Patients with Acute Lymphoblastic Leukemia (ALL) up to the Age of 40: Results From the Dutch-Belgian HOVON-70 Study.

A. W Rijneveld, B. van der Holt, S. M. G. J. Daenen, B. J. Biemond, A. A van de Loosdrecht, O. de Weerdt, P. Muus, J. Maertens, V. Mattijssen, H. Demuynck, Mcjc Legdeur, P.W. Wijermans, S. Wittebol, F. Spoelstra, A. W. Dekker, G.J. Ossenkoppele, J. J. Cornelissen, R. Willemze
Journal: Blood
Blood (2009) 114 (22): 323.
https://doi.org/10.1182/blood.V114.22.323.323
Published: 2009